Location: Home
  • search
  • go
  • Relate News
  • 10/12/2018Eisai's NDA for Antiepileptic Drug Perampanel Accepted in China
  • 10/12/2018Mesoblast and Tasly Complete Strategic Cardiovascular Partnership in C...
  • 10/11/2018NEJM and CCA Enter Partnership for CVS Research and Training
  • 10/11/2018MEI Pharma and BeiGene Announce Collaboration for ME-401/Zanubrutinib ...
  • 10/10/2018SMIA Issues Official Notice on Approval of 17 Anticancer Drugs for BMI...
  • 10/9/2018Daiichi Sankyo Enters Deal with MVP for Distribution of Pain Medicine ...
  • 10/9/2018Listed Chinese Pharma Cos Reports Positive Performance in H1
  • 10/8/2018CDE Solicits Comments on Technical Requirements for Manufacturing Site...
  • 10/8/2018NMPA Issues Rules for Communications Related to Drug R&D and Techn...
  • 10/8/2018Biosimilars and Healthcare Policy: What China Can Learn from the EU an...
  • 10/8/2018Amyris Enters into Extensive Partnership with Yifan Pharma
  • 10/8/2018Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs
  • 10/8/2018SCMP: Betting Big on Biotech
  • 9/28/2018Recent Official and Executive Moves
  • 9/28/2018Novartis Enters Deal with CBMG to Make CAR-T Therapy Kymriah
  • 9/27/2018China’s Health Authorities Issue New Rules on Telemedicine
  • 9/27/2018I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics
  • 9/27/2018Alvotech and Changchun HiTech Agree to Codevelop Biosimilars in China
  • 9/27/2018PharmaBlock Acquires Manufacturing Facility in China
  • 9/27/2018The Development of Antibody-drug Conjugates in China
  • 9/26/2018NMPA Restores Import of Cubist Pharma’s Cubicin after Re-inpsection
  • 9/26/2018Reuters: As China Builds Biotech Sector, Cash Floods U.S. Startups
  • 9/26/2018Flow Pharma Forms Chinese JV for FlowVax Vaccines
  • 9/25/2018China to Begin Clinical Trials of New HPV Vaccine with Help of Gardasi...
  • 9/25/2018Chinese Pharma Market Primed for Growth after Sweeping Reforms
  • 9/25/2018CSPC Pharma and Verastem Oncology Sign Exclusive License for Anticance...
  • 9/25/2018AZ and MSD Publish Retail Price of First PARP inhibitor for Ovarian Ca...
  • 9/21/2018Recent Executive Moves
  • 9/21/2018Impending Tariffs on China to Impact Manufacturers of Dietary Suppleme...
  • 9/20/2018CDE Solicits Comments on Core Considerations for Clinical Protocol Des...
  • Page:131/334 Total number of articles:9998: [First][<<] [129] [130] [131] [132] [133] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group